As part of its global campaign to raise awareness for rare diseases and the Americans afflicted by them, the FDA has highlighted Epidermolysis Bullosa (EB) and the Jackson Gabriel Silver Foundation. JGSF founder Alexander Silver said “We’re honored that the FDA is helping to raise EB awareness and the need for resources to fund cures for all rare diseases”. The Official FDA release can be found on the JGSF website: http://jgsf.org/news-coverage.html